MAY 14, 2020 6:42 AM PDT

Antibody-laden Nanoparticles to Help COVID Patients Breathe Easy

WRITTEN BY: Tara Fernandez

 

Antibodies are a powerful countermeasure against COVID-19. Not only can they relieve symptoms in patients experiencing severe forms of the disease, but they can also be deployed as a “temporary vaccine”, protecting vulnerable individuals from infection.

Biopharmaceutical companies are working on an inhaled COVID-19 drug consisting of aerosolized nanoparticles containing mRNA antibodies. These nanoparticles can penetrate tissues and deliver the genetic instructions for the antibodies, in the form of mRNA, directly into cells lining the respiratory tract. In response, the cellular machinery then produces and releases high levels of the virus-binding antibody into the lungs, neutralizing SARS-CoV-2 and resisting infection.

In a pandemic situation, mRNA drugs can be swiftly deployed and accelerated through drug development pipelines. This approach was successfully demonstrated in 2019 against another viral pathogen, the Chikungunya virus. Here, mRNA antibodies administered to healthy adults protected them against severe infection from the mosquito-borne virus.

A similar approach could help ease the ongoing COVID-19 crisis. Gita Dittmar, CEO of  German RNA biotech, Ethris, said, “To cure COVID-19, the virus has to be cleared systemically. This may eventually be achieved by the patients’ natural immune response against the virus, or, once developed, by systemic treatments against the virus.”

“Our goal is to rapidly treat lung disease in patients with COVID-19 to gain time for systemic clearance of the virus and to reduce major lung complications,” Dittmar explains.

The drug development project is a collaboration between Ethris and Swiss antibody company, Neurimmune. The company has another human monoclonal antibody for the treatment of early Alzheimer’s disease currently in development.

While there are currently no clinically-approved mRNA drugs on the market, evidence from similar therapeutics in development suggest that such treatments could be safe and effective. This drug joins a long list of other pharmaceutical agents against SARS-CoV-2 that are being evaluated, from antiviral therapies to anti-inflammatory treatments.

 

 

Sources: Labiotech, Neurimmune, Ethris.

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
SEP 28, 2020
Genetics & Genomics
Why Some Young, Healthy People Get Severe COVID-19
SEP 28, 2020
Why Some Young, Healthy People Get Severe COVID-19
Since the start of the pandemic, scientists have been trying to find out why some people get such severe illness from SA ...
OCT 14, 2020
Immunology
Happiness Linked to Heart Attack Risk
OCT 14, 2020
Happiness Linked to Heart Attack Risk
Asking patients questions about their personal lives could predict their future risk of a heart attack. A study, publish ...
OCT 20, 2020
Immunology
The Immune Pause Button Slowing MS Progression
OCT 20, 2020
The Immune Pause Button Slowing MS Progression
  Scientists have a new theory about the genetics behind the progressive, debilitating effects of multiple sclerosi ...
NOV 12, 2020
Health & Medicine
Measles Cases and Deaths Surge Worldwide
NOV 12, 2020
Measles Cases and Deaths Surge Worldwide
Today, the World Health Organization (WHO) and the U.S. Centers for Disease Control and Prevention (CDC) released a stat ...
DEC 23, 2020
Cell & Molecular Biology
Similarities Between Two Proteins May Impair One's Activity
DEC 23, 2020
Similarities Between Two Proteins May Impair One's Activity
Cytokines are a group of molecules that are involved in several processes including cell signaling and inflammation, the ...
DEC 23, 2020
Immunology
COVID Survivors Stay Immune for at Least a Year
DEC 23, 2020
COVID Survivors Stay Immune for at Least a Year
Once the coronavirus enters the body, the immune system springs into action, producing antibodies that bind to and neutr ...
Loading Comments...